VX-509
VX11-509-102
Phase 3 small_molecule completed
Quick answer
VX-509 for Rheumatoid Arthritis is a Phase 3 program (small_molecule) at Vertex Pharmaceuticals (Ireland) Limited with 3 ClinicalTrials.gov record(s).
Program details
- Company
- Vertex Pharmaceuticals (Ireland) Limited
- Indication
- Rheumatoid Arthritis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed